KBC Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Buy
14,566
+731
+5% +$91.8K ﹤0.01% 600
2025
Q1
$1.53M Sell
13,835
-495
-3% -$54.7K ﹤0.01% 628
2024
Q4
$1.96M Sell
14,330
-4,642
-24% -$634K 0.01% 690
2024
Q3
$2.19M Buy
18,972
+8,332
+78% +$960K 0.01% 605
2024
Q2
$1.47M Buy
10,640
+152
+1% +$20.9K ﹤0.01% 625
2024
Q1
$1.45M Sell
10,488
-94
-0.9% -$13K ﹤0.01% 628
2023
Q4
$1.39M Sell
10,582
-8,270
-44% -$1.09M ﹤0.01% 651
2023
Q3
$2.12M Sell
18,852
-12,685
-40% -$1.43M 0.01% 579
2023
Q2
$2.97M Buy
31,537
+3,384
+12% +$319K 0.01% 543
2023
Q1
$2.85M Sell
28,153
-808
-3% -$81.8K 0.01% 593
2022
Q4
$3.46M Buy
28,961
+25,979
+871% +$3.1M 0.02% 503
2022
Q3
$317K Sell
2,982
-42
-1% -$4.47K ﹤0.01% 845
2022
Q2
$295K Buy
3,024
+185
+7% +$18K ﹤0.01% 870
2022
Q1
$266K Sell
2,839
-6,239
-69% -$585K ﹤0.01% 974
2021
Q4
$773K Sell
9,078
-3,103
-25% -$264K ﹤0.01% 771
2021
Q3
$1.17M Sell
12,181
-12,181
-50% -$1.17M ﹤0.01% 739
2021
Q2
$2.37M Hold
24,362
﹤0.01% 745
2021
Q1
$2.37M Hold
24,362
﹤0.01% 729
2020
Q4
$12.8M Hold
24,362
0.01% 728
2020
Q3
$2.34M Hold
24,362
0.01% 683
2020
Q2
$2.97M Buy
24,362
+19,235
+375% +$2.35M 0.01% 621
2020
Q1
$444K Hold
5,127
﹤0.01% 873
2019
Q4
$551K Buy
+5,127
New +$551K ﹤0.01% 1076
2019
Q3
Sell
-110
Closed -$10K 1493
2019
Q2
$10K Hold
110
﹤0.01% 1436
2019
Q1
$10K Hold
110
﹤0.01% 1394
2018
Q4
$8K Hold
110
﹤0.01% 1294
2018
Q3
$14K Hold
110
﹤0.01% 1374
2018
Q2
$11K Hold
110
﹤0.01% 1280
2018
Q1
$9K Buy
+110
New +$9K ﹤0.01% 1265